Article info
PDFCervical Cancer
PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia: A Meta-analysis of Related Studies
- Address correspondence and reprint requests to Xin Zeng, PhD, Nanjing Maternity and Child Health Medical Institute, Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University, 210004 Nanjing, China. E-mail: august555482{at}126.com; or Ping Li. E-mail: liping0099{at}126.com.
Citation
PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia: A Meta-analysis of Related Studies
Publication history
- Received February 8, 2017
- Accepted March 17, 2017
- First published September 1, 2017.
Online issue publication
September 01, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2017 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.